TUG1 and acute lymphoblastic leukemia: In conclusion, lncRNA TUG1 is upregulated and correlates with poor disease condition, treatment response, and survival profiles in Ph− ALL patients, implying the potential of lncRNA TUG1 as a useful biomarker in ALL management.